TY - JOUR AU - Rini, B I; Plimack, E R; Stus, V TI - KEYNOTE-426 Investigators. Pembrolizumab plus axitinib versus sunitinib for advanced renal-cell carcinoma JO - N Engl J Med IS - 12 VL - 380 PY - 2019 DO - 10.1056/NEJMoa1816714 L3 - PubMed-ID: 30779529 SP - 1116 EP - 1127 ER -